The clinical entity with which this report deals was first described about ten years ago. Since then it has been reported by observers in Australia, Europe and North America. There has been a difference of opinion as to a proper name for the disease. Although the literature on the subject is not particularly voluminous, a review of it will demonstrate clearly the causes for this lack of unanimity. The names most commonly employed at present are erythredema-polyneuritis, erythredema, pink disease, Swift's disease, acrodynia and Feer's disease. This multiplicity of names has grown chiefly out of insufficient information concerning the etiology, pathology, pathogenesis and even the clinical characteristics of the disease to classify it or to name it properly.
Weston,1 who is responsible for the term acrodynia, which is probably the most widely used at present, applied it to a group of cases reviewed by Bilderbach.2 In a superficial
KERNOHAN JW, KENNEDY RLJ. ACRODYNIA (SO-CALLED): A STUDY OF THE PATHOLOGY. Am J Dis Child. 1928;36(2):341–351. doi:10.1001/archpedi.1928.01920260149011
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: